SCHEMBL17035129

SCHEMBL17035129

Brc1cc(-c2cccnc2)cc(-c2cc3c(-c4ccccc4)nc4ccccc4c3c3ccccc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.43
DHODH Q02127 1/20 0.40
CYP11B2 P19099 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP19A1 P11511 1/20 0.39
KMT2A Q03164 3/20 0.38
RXFP1 Q9HBX9 2/20 0.38
F2 P00734 1/20 0.38
HPGD P15428 1/20 0.38
G6PD P11413 1/20 0.38
USP1 O94782 1/20 0.38
WDR48 Q8TAF3 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
PRNP P04156 1/20 0.38
PPARG P37231 1/20 0.38
NR2E3 Q9Y5X4 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CLK4 Q9HAZ1 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034960 0.94 CYP11B1 (0.48) CYP11B1DHODHCYP11B2CYP2A6CYP19A1
SCHEMBL17035023 0.94 CYP11B1 (0.48) CYP11B1DHODHCYP11B2CYP2A6CYP19A1
SCHEMBL17035130 0.89 PRNP (0.41) DHODHKMT2ARXFP1HPGDNPSR1
SCHEMBL17035004 0.88 CYP1A2 (0.45) CYP11B1DHODHCYP2A6KMT2ANPSR1
SCHEMBL17034961 0.87 DHODH (0.49) CYP11B1DHODHCYP11B2CYP2A6CYP19A1
SCHEMBL17035017 0.86 CYP1A2 (0.44) CYP11B1DHODHCYP2A6CYP19A1KMT2A
SCHEMBL17035019 0.86 CYP11B1 (0.44) CYP11B1DHODHCYP11B2CYP2A6CYP19A1
SCHEMBL18907245 0.85 CYP11B1 (0.47) CYP11B1DHODHCYP11B2CYP2A6CYP19A1
SCHEMBL17035127 0.85 DHODH (0.43) CYP11B1DHODHCYP11B2CYP2A6CYP19A1
SCHEMBL17034962 0.84 DHODH (0.49) CYP11B1DHODHCYP11B2CYP2A6CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 781/4885DHODH 2312/4885CYP11B2 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.